Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
August 01, 2024 at 08:01 AM EDT
The data adds to mounting evidence that Zepbound and other popular GLP-1 drugs have health benefits beyond promoting weight loss and regulating blood sugar.
